Table 2.
Demographic and clinicopathological characteristics of the tumour samples in the clinical cohort.
| Number of cases | Percentage (%) | |
|---|---|---|
| Age at diagnosis (y) | ||
| ≤ 50 | 23 | 6.7 |
| > 50 | 318 | 93.3 |
| N/Aa | 19 | - |
| BMI (kg/m2) | ||
| ≤ 30 | 179 | 53.0 |
| > 30 | 159 | 47.0 |
| N/A | 22 | – |
| Tumour grade | ||
| 1 | 151 | 41.9 |
| 2 | 100 | 27.8 |
| 3 | 109 | 30.3 |
| FIGO stage (2009) | ||
| I | 267 | 76.1 |
| II | 26 | 7.4 |
| III | 43 | 12.3 |
| IV | 15 | 4.3 |
| N/A | 9 | – |
| Histological subtype | ||
| Endometrioid | 283 | 79.1 |
| Serous | 33 | 9.2 |
| Clear cell | 14 | 3.9 |
| Mucinous | 1 | 0.3 |
| MMMTb | 20 | 5.6 |
| Mixed | 7 | 2.0 |
| N/A | 2 | – |
| Menopause status | ||
| Peri | 14 | 4.1 |
| Pre | 32 | 9.4 |
| Post | 295 | 86.5 |
| N/A | 19 | – |
aData not available, bMalignant mixed Müllerian tumour.